Azmasol Respirator Solution 2.5 mg/3 ml contains Salbutamol, a well-established short-acting beta-2 adrenergic agonist used for rapid relief of bronchospasm in patients with reversible airway obstruction. This ready-to-use nebulizer solution is specifically designed to deliver accurate dosing and fast bronchodilation, making it highly suitable for use in hospitals, clinics, and home settings under medical supervision.

Azmasol Respirator Solution is particularly beneficial for patients who experience difficulty using inhalers, such as young children, elderly individuals, and patients during acute asthma attacks. By directly targeting the lungs through nebulization, it ensures quick symptom control and improved breathing comfort.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Azmasol Respirator Solution 2.5 mg/3 ml is indicated for the treatment and prevention of bronchospasm associated with:

• Bronchial asthma

• Chronic obstructive pulmonary disease (COPD)

• Chronic bronchitis and emphysema

• Acute episodes of wheezing and shortness of breath

• Exercise-induced bronchospasm

It is effective for both acute relief and regular maintenance therapy as prescribed by a healthcare professional.

Therapeutic Class

Short-acting beta-2 adrenergic agonist (Bronchodilator)

Pharmacology

Salbutamol works by selectively stimulating beta-2 adrenergic receptors located in bronchial smooth muscle. Activation of these receptors leads to relaxation of airway muscles, resulting in bronchodilation and improved airflow. This mechanism helps relieve symptoms such as wheezing, chest tightness, coughing, and breathlessness.

When administered via nebulization, salbutamol acts rapidly, with onset of bronchodilation usually occurring within minutes. The effect typically lasts for 4 to 6 hours. Due to localized delivery to the lungs, systemic absorption is limited, which reduces the risk of adverse effects when used at recommended doses.

Dosage and Administration

Adults and Elderly:
One unit dose of 2.5 mg (3 ml) administered via nebulizer up to 3–4 times daily or as directed by the physician.

Children:
One unit dose of 2.5 mg (3 ml) via nebulizer, with dosage frequency adjusted according to age, severity of symptoms, and clinical response.

Azmasol Respirator Solution should be administered using appropriate nebulizing equipment. No dilution is usually required unless advised by a healthcare professional.

Drug Interactions

Caution is advised when Azmasol Respirator Solution is used with non-selective beta-blockers, as they may antagonize the bronchodilating effect. Concurrent use with other sympathomimetic agents, diuretics, or xanthine derivatives may increase the risk of side effects such as hypokalemia. Careful monitoring is recommended when used alongside monoamine oxidase inhibitors or tricyclic antidepressants.

Contraindications

Azmasol Respirator Solution is contraindicated in patients with known hypersensitivity to salbutamol or any component of the formulation. It should be used with caution in patients with cardiovascular disease, hypertension, hyperthyroidism, diabetes mellitus, or a history of cardiac arrhythmias.

Side Effects

Common side effects include tremor, nervousness, headache, palpitations, muscle cramps, and mild throat irritation. Less common effects may include tachycardia, dizziness, or transient hypokalemia, particularly with frequent or high-dose use.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Pregnancy & Lactation

Salbutamol should be used during pregnancy only if clearly needed and prescribed by a physician. Caution is advised during breastfeeding, as small amounts of salbutamol may pass into breast milk.

Storage Conditions

Store below 30°C in a dry place, protected from light. Keep out of reach of children.